Clinical Trial of Favipiravir Treatment of Patients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

December 28, 2020

Study Completion Date

December 28, 2020

Conditions
SARS-CoV-2 Infection
Interventions
DRUG

Favipiravir

Name: AVIGAN Generic name: Favipiravir Content: T-705a tablets \[200\]

Trial Locations (5)

1083

Department of Pulmonology Semmelweis University, Budapest

1121

National Korányi Institute for Pulmonology, Budapest

4031

Institute of Infectology, University of Debrecen, Debrecen

6720

First Department of Internal Medicine, University of Szeged, Szeged

7624

1st Department of Medicine, University of Pécs, Pécs

All Listed Sponsors
collaborator

HECRIN Consortium

UNKNOWN

collaborator

Hungarian Ministry of Innovation and Technology

UNKNOWN

lead

University of Pecs

OTHER

NCT04600999 - Clinical Trial of Favipiravir Treatment of Patients With COVID-19 | Biotech Hunter | Biotech Hunter